Comparison of Tumor-Associated Vasculatures in Uveal and Cutaneous Melanomas

REFERENCES

• Warren B A, Shubik P. The growth of the blood supply to melanoma transplants in the hamster cheek pouch. Lab Invest 1966; 15(2)464–478
   PubMedGoogle Scholar
• Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971; 285(21)1182–1186
   PubMed Web of Science ®Google Scholar
• Folkman J. What is the role of angiogenesis in metastasis from cutaneous melanoma?. Eur J Cancer Clin Oncol 1987; 23(4)361–363
   PubMedGoogle Scholar
• Folkman J, Hanahan D. Switch to the angiogenic phenotype during tumorigenesis. Princess Takamatsu Symp 1991; 22: 339–347
   PubMedGoogle Scholar
• Le Querrec A, Duval D, Tobelem G. Tumour angiogenesis. Baillieres Clin Haematol 1993; 6(3)711–730
   PubMedGoogle Scholar
• Folberg R, Hendrix M J, Maniotis A J. Vasculogenic mimicry and tumor angiogenesis. Am J Pathol 2000; 156(2)361–381
   PubMed Web of Science ®Google Scholar
• Shields C L. The hunt for the secrets of uveal melanoma. Clin Experiment Ophthalmol 2008; 36(3)277–280
   PubMedGoogle Scholar
• Sato T, Han F, Yamamoto A. The biology and management of uveal melanoma. Curr Oncol Rep 2008; 10(5)431–438
   PubMedGoogle Scholar
• McLean I W, Saraiva V S, Burnier M N, Jr. Pathological and prognostic features of uveal melanomas. Can J Ophthalmol 2004; 39(4)343–350
   PubMedGoogle Scholar
• McLean I W. The biology of haematogenous metastasis in human uveal malignant melanoma. Virchows Arch A Pathol Anat Histopathol 1993; 422(6)433–437
   PubMedGoogle Scholar
• Folberg R, Pe'er J, Gruman L M, et al. The morphologic characteristics of tumor blood vessels as a marker of tumor progression in primary human uveal melanoma: a matched case-control study. Hum Pathol 1992; 23(11)1298–1305
   PubMedGoogle Scholar
• Shields J A, Augsburger J J, Brady L W, Day J L. Cobalt plaque therapy of posterior uveal melanomas. Ophthalmology 1982; 89(10)1201–1207
   PubMedGoogle Scholar
• Gragoudas E S, Goitein M, Verhey L, et al. Proton beam irradiation. An alternative to enucleation for intraocular melanomas. Ophthalmology 1980; 87(6)571–581
   PubMedGoogle Scholar
• Seregard S, Spangberg B, Juul C, Oskarsson M. Prognostic accuracy of the mean of the largest nucleoli, vascular patterns, and PC-10 in posterior uveal melanoma. Ophthalmology 1998; 105(3)485–491
   PubMedGoogle Scholar
• Sakamoto T, Sakamoto M, Yoshikawa H, et al. Histologic findings and prognosis of uveal malignant melanoma in japanese patients. Am J Ophthalmol 1996; 121(3)276–283
   PubMedGoogle Scholar
• McLean I W, Keefe K S, Burnier M N. Uveal melanoma. Comparison of the prognostic value of fibrovascular loops, mean of the ten largest nucleoli, cell type, and tumor size. Ophthalmology 1997; 104(5)777–780
   PubMedGoogle Scholar
• Maniotis A J, Folberg R, Hess A, et al. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 1999; 155(3)739–752
   PubMed Web of Science ®Google Scholar
• Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275(5302)964–967
   PubMed Web of Science ®Google Scholar
• Holash J, Maisonpierre P C, Compton D, et al. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 1999; 284(5422)1994–1998
   PubMed Web of Science ®Google Scholar
• Mueller A J, Bartsch D U, Folberg R, et al. Imaging the microvasculature of choroidal melanomas with confocal indocyanine green scanning laser ophthalmoscopy. Arch Ophthalmol 1998; 116(1)31–39
   PubMedGoogle Scholar
• Maniotis A J, Chen X, Garcia C, et al. Control of melanoma morphogenesis, endothelial survival, and perfusion by extracellular matrix. Lab Invest 2002; 82(8)1031–1043
   PubMedGoogle Scholar
• Seftor R E, Seftor E A, Koshikawa N, et al. Cooperative interactions of laminin 5 gamma2 chain, matrix metalloproteinase-2, and membrane type-1-matrix/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma. Cancer Res 2001; 61(17)6322–6327
   PubMedGoogle Scholar
• Clarijs R, Otte-Holler I, Ruiter D J, de Waal R M. Presence of a fluid-conducting meshwork in xenografted cutaneous and primary human uveal melanoma. Invest Ophthalmol Vis Sci 2002; 43(4)912–918
   PubMedGoogle Scholar
• Lin A Y, Maniotis A J, Valyi-Nagy K, et al. Distinguishing fibrovascular septa from vasculogenic mimicry patterns. Arch Pathol Lab Med 2005; 129(7)884–892
   PubMedGoogle Scholar
• Daniels K J, Boldt H C, Martin J A, et al. Expression of type VI collagen in uveal melanoma: its role in pattern formation and tumor progression. Lab Invest 1996; 75(1)55–66
   PubMedGoogle Scholar
• Smetsers T F, van de Westerlo E M, ten Dam G B, et al. Localization and characterization of melanoma-associated glycosaminoglycans: differential expression of chondroitin and heparan sulfate epitopes in melanoma. Cancer Res 2003; 63(11)2965–2970
   PubMedGoogle Scholar
• Chen X, Ai Z, Rasmussen M, et al. Three-dimensional reconstruction of extravascular matrix patterns and blood vessels in human uveal melanoma tissue: techniques and preliminary findings. Invest Ophthalmol Vis Sci 2003; 44(7)2834–2840
   PubMedGoogle Scholar
• Lin A Y, Ai Z, Lee S C, et al. Comparing vasculogenic mimicry with endothelial cell-lined vessels: techniques for 3D reconstruction and quantitative analysis of tissue components from archival paraffin blocks. Appl Immunohistochem Mol Morphol 2007; 15(1)113–119
   PubMedGoogle Scholar
• Makitie T, Summanen P, Tarkkanen A, Kivela T. Microvascular density in predicting survival of patients with choroidal and ciliary body melanoma. Invest Ophthalmol Vis Sci 1999; 40(11)2471–2480
   PubMedGoogle Scholar
• Folberg R, Mehaffey M, Gardner L M, et al. The microcirculation of choroidal and ciliary body melanomas. Eye 1997; 11: 227–238, (Pt 2)
   PubMed Web of Science ®Google Scholar
• Folberg R, Maniotis A J. Vasculogenic mimicry. Apmis 2004; 112(7–8)508–525
   PubMedGoogle Scholar
• Frenkel S, Barzel I, Levy J, et al. Demonstrating circulation in vasculogenic mimicry patterns of uveal melanoma by confocal indocyanine green angiography. Eye 2008; 22(7)948–952
   PubMed Web of Science ®Google Scholar
• Prescher G, Bornfeld N, Hirche H, et al. Prognostic implications of monosomy 3 in uveal melanoma. Lancet 1996; 347(9010)1222–1225
   PubMed Web of Science ®Google Scholar
• Scholes A G, Damato B E, Nunn J, et al. Monosomy 3 in uveal melanoma: correlation with clinical and histologic predictors of survival. Invest Ophthalmol Vis Sci 2003; 44(3)1008–1011
   PubMed Web of Science ®Google Scholar
• Rummelt V, Mehaffey M G, Campbell R J, et al. Microcirculation architecture of metastases from primary ciliary body and choroidal melanomas. Am J Ophthalmol 1998; 126(2)303–305
   PubMedGoogle Scholar
• Kivela T, Makitie T, Al-Jamal R T, Toivonen P. Microvascular loops and networks in uveal melanoma. Can J Ophthalmol 2004; 39(4)409–421
   PubMedGoogle Scholar
• Landis S H, Murray T, Bolden S, Wingo P A. Cancer statistics, 1999. CA Cancer J Clin 1999; 49(1)8–31; 1
   PubMed Web of Science ®Google Scholar
• Streit M, Detmar M. Angiogenesis, lymphangiogenesis, and melanoma metastasis. Oncogene 2003; 22(20)3172–3179
   PubMed Web of Science ®Google Scholar
• Barnhill R L, Mihm M C, Jr., Ceballos P I. Angiogenesis and regressing cutaneous malignant melanoma. Lancet 1992; 339(8799)991–992
   PubMedGoogle Scholar
• Wolf J E, Jr., Hubler W R, Jr. Tumor angiogenic factor and human skin tumors. Arch Dermatol 1975; 111(3)321–327
   PubMedGoogle Scholar
• Hubler W R, Jr., Wolf J E, Jr. Melanoma. Tumor angiogenesis and human neoplasia. Cancer 1976; 38(1)187–192
   PubMedGoogle Scholar
• Srivastava A, Laidler P, Hughes L E, et al. Neovascularization in human cutaneous melanoma: a quantitative morphological and Doppler ultrasound study. Eur J Cancer Clin Oncol 1986; 22(10)1205–1209
   PubMedGoogle Scholar
• Dadras S S, Detmar M. Angiogenesis and lymphangiogenesis of skin cancers. Hematol Oncol Clin North Am 2004; 18(5)1059–1070; viii
   PubMedGoogle Scholar
• Srivastava A, Laidler P, Davies R P, et al. The prognostic significance of tumor vascularity in intermediate-thickness (0.76–4.0 mm thick) skin melanoma. A quantitative histologic study. Am J Pathol 1988; 133(2)419–423
   PubMed Web of Science ®Google Scholar
• Vlaykova T, Laurila P, Muhonen T, et al. Prognostic value of tumour vascularity in metastatic melanoma and association of blood vessel density with vascular endothelial growth factor expression. Melanoma Res 1999; 9(1)59–68
   PubMedGoogle Scholar
• Kashani-Sabet M, Sagebiel R W, Ferreira C M, et al. Tumor vascularity in the prognostic assessment of primary cutaneous melanoma. J Clin Oncol 2002; 20(7)1826–1831
   PubMed Web of Science ®Google Scholar
• Carnochan P, Briggs J C, Westbury G, Davies A J. The vascularity of cutaneous melanoma: a quantitative histological study of lesions 0.85–1.25 mm in thickness. Br J Cancer 1991; 64(1)102–107
   PubMedGoogle Scholar
• Busam K J, Berwick M, Blessing K, et al. Tumor vascularity is not a prognostic factor for malignant melanoma of the skin. Am J Pathol 1995; 147(4)1049–1056
   PubMedGoogle Scholar
• Nowak M A, Fatteh S M, Campbell T E. Glycogen-rich malignant melanomas and glycogen-rich balloon cell malignant melanomas: frequency and pattern of PAS positivity in primary and metastatic melanomas. Arch Pathol Lab Med 1998; 122(4)353–360
   PubMedGoogle Scholar
• Sun B C, Zhang S W, Zhao X L, Hao X S. [Study on vasculogenic mimicry in malignant melanoma]. Zhonghua Bing Li Xue Za Zhi 2003; 32(6)539–543
   PubMedGoogle Scholar
• Massi D, Franchi A, Paglierani M, et al. Vasculogenic mimicry has no prognostic significance in pT3 and pT4 cutaneous melanoma. Hum Pathol 2004; 35(4)496–502
   PubMedGoogle Scholar